North Berkeley Wealth Management, LLC Biocryst Pharmaceuticals Inc Transaction History
North Berkeley Wealth Management, LLC
- $98.5 Billion
- Q4 2024
A detailed history of North Berkeley Wealth Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, North Berkeley Wealth Management, LLC holds 13,065 shares of BCRX stock, worth $109,615. This represents 0.1% of its overall portfolio holdings.
Number of Shares
13,065Holding current value
$109,615% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
283Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$167 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$99.5 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$76.2 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$68.3 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.56B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...